{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:33:31Z","timestamp":1790940811165,"version":"4.1.0"},"reference-count":318,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8,1]]},"DOI":"10.1210\/er.2012-1050","type":"journal-article","created":{"date-parts":[[2013,8,6]],"date-time":"2013-08-06T17:40:39Z","timestamp":1375810839000},"page":"525-555","source":"Crossref","is-referenced-by-count":179,"title":["11\u03b2-Hydroxysteroid Dehydrogenase 1: Translational and Therapeutic Aspects"],"prefix":"10.1210","volume":"34","author":[{"given":"Laura L.","family":"Gathercole","sequence":"first","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth G.","family":"Lavery","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J.","family":"Sinclair","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy W.","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041121523310200_B1","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1016\/0303-7207(92)90091-J","article-title":"The ups and downs of glucocorticoid physiology. Permissive and suppressive effects revisited","volume":"90","author":"Munck","year":"1992","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121523310200_B2","first-page":"147","article-title":"The behaviour of 14c-cortisol and estimation of cortisol production rate in man","volume":"17","author":"Cope","year":"1958","journal-title":"Clin Sci (Lond)"},{"key":"2019041121523310200_B3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jcem-72-1-39","article-title":"Daily cortisol production rate in man determined by stable isotope dilution\/mass spectrometry","volume":"72","author":"Esteban","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B4","first-page":"457","article-title":"The serum transport of steroid hormones","volume":"38","author":"Siiteri","year":"1982","journal-title":"Recent Prog Horm Res"},{"key":"2019041121523310200_B5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/clinchem\/36.1.70","article-title":"Differences between concentrations of salivary cortisol and cortisone and of free cortisol and cortisone in plasma during pregnancy and postpartum","volume":"36","author":"Meulenberg","year":"1990","journal-title":"Clin Chem"},{"key":"2019041121523310200_B6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0039-128X(84)80001-X","article-title":"11 \u03b2-Hydroxysteroid dehydrogenase: fact or fancy?","volume":"44","author":"Monder","year":"1984","journal-title":"Steroids"},{"key":"2019041121523310200_B7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0083-6729(08)60447-1","article-title":"11 \u03b2-Hydroxysteroid dehydrogenase","volume":"47","author":"Monder","year":"1993","journal-title":"Vitam Horm"},{"key":"2019041121523310200_B8","first-page":"121","volume-title":"Cortisone: Memoirs of a hormone hunter","author":"Kendell","year":"1971"},{"key":"2019041121523310200_B9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/er.2003-0031","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response","volume":"25","author":"Tomlinson","year":"2004","journal-title":"Endocr Rev"},{"key":"2019041121523310200_B10","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","article-title":"Localisation of 11 \u03b2-hydroxysteroid dehydrogenase\u2014tissue specific protector of the mineralocorticoid receptor","volume":"2","author":"Edwards","year":"1988","journal-title":"Lancet"},{"key":"2019041121523310200_B11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0039-128X(96)00164-X","article-title":"Molecular analysis of 11 \u03b2-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess","volume":"62","author":"White","year":"1997","journal-title":"Steroids"},{"key":"2019041121523310200_B12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0083-6729(08)60646-9","article-title":"11 \u03b2-Hydroxysteroid dehydrogenase","volume":"57","author":"Stewart","year":"1999","journal-title":"Vitam Horm"},{"key":"2019041121523310200_B13","doi-asserted-by":"crossref","first-page":"28762","DOI":"10.1074\/jbc.274.40.28762","article-title":"The N-terminal anchor sequences of 11\u03b2-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane","volume":"274","author":"Odermatt","year":"1999","journal-title":"J Biol Chem"},{"key":"2019041121523310200_B14","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1074\/jbc.270.5.2305","article-title":"Lumenal orientation and posttranslational modifications of the liver microsomal 11-\u03b2-hydroxysteroid dehydrogenase","volume":"270","author":"Ozols","year":"1995","journal-title":"J Biol Chem"},{"key":"2019041121523310200_B15","doi-asserted-by":"crossref","first-page":"18939","DOI":"10.1016\/S0021-9258(19)47248-7","article-title":"Cloning and expression of rat cDNA encoding corticosteroid 11 \u03b2-dehydrogenase","volume":"264","author":"Agarwal","year":"1989","journal-title":"J Biol Chem"},{"key":"2019041121523310200_B16","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1210\/endo-123-5-2390","article-title":"Purification and characterization of the corticosteroid 11 \u03b2-dehydrogenase component of the rat liver 11 \u03b2-hydroxysteroid dehydrogenase complex","volume":"123","author":"Lakshmi","year":"1988","journal-title":"Endocrinology"},{"key":"2019041121523310200_B17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0022-4731(89)90017-4","article-title":"Evidence for kinetically distinct forms of corticosteroid 11 \u03b2-dehydrogenase in rat liver microsomes","volume":"32","author":"Monder","year":"1989","journal-title":"J Steroid Biochem"},{"key":"2019041121523310200_B18","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1021\/bi015803t","article-title":"11 \u03b2-hydroxysteroid dehydrogenase type 1 from human liver: dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase","volume":"41","author":"Maser","year":"2002","journal-title":"Biochemistry"},{"key":"2019041121523310200_B19","first-page":"480","article-title":"Human kidney 11 \u03b2-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform","volume":"79","author":"Stewart","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B20","doi-asserted-by":"crossref","first-page":"16653","DOI":"10.1016\/S0021-9258(18)55351-5","article-title":"The human gene for 11 \u03b2-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization","volume":"266","author":"Tannin","year":"1991","journal-title":"J Biol Chem"},{"key":"2019041121523310200_B21","first-page":"1205","article-title":"A switch in dehydrogenase to reductase activity of 11 \u03b2-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells","volume":"87","author":"Bujalska","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B22","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1210\/endo.142.4.8114","article-title":"Minireview: 11\u03b2-hydroxysteroid dehydrogenase type 1\u2014a tissue-specific amplifier of glucocorticoid action","volume":"142","author":"Seckl","year":"2001","journal-title":"Endocrinology"},{"key":"2019041121523310200_B23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0960-0760(99)00133-8","article-title":"11 \u03b2-hydroxysteroid dehydrogenase functions reversibly as an oxidoreductase in the rat hippocampus in vivo","volume":"71","author":"Jellinck","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121523310200_B24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ng1214","article-title":"Mutations in the genes encoding 11\u03b2-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency","volume":"34","author":"Draper","year":"2003","journal-title":"Nat Genet"},{"key":"2019041121523310200_B25","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1210\/endo-126-5-2435","article-title":"Corticosteroid 11 \u03b2-dehydrogenase of rat tissues: immunological studies","volume":"126","author":"Monder","year":"1990","journal-title":"Endocrinology"},{"key":"2019041121523310200_B26","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1210\/jc.2008-0743","article-title":"Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency","volume":"93","author":"Lavery","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B27","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1210\/en.2007-0963","article-title":"Hypoglycemia with enhanced hepatic glycogen synthesis in recombinant mice lacking hexose-6-phosphate dehydrogenase","volume":"148","author":"Lavery","year":"2007","journal-title":"Endocrinology"},{"key":"2019041121523310200_B28","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1210\/en.2007-0593","article-title":"Abnormalities of glucose homeostasis and the hypothalamic-pituitary-adrenal axis in mice lacking hexose-6-phosphate dehydrogenase","volume":"148","author":"Rogoff","year":"2007","journal-title":"Endocrinology"},{"key":"2019041121523310200_B29","doi-asserted-by":"crossref","first-page":"27030","DOI":"10.1074\/jbc.M704144200","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 regulation by intracellular glucose 6-phosphate provides evidence for a novel link between glucose metabolism and hypothalamo-pituitary-adrenal axis function","volume":"282","author":"Walker","year":"2007","journal-title":"J Biol Chem"},{"key":"2019041121523310200_B30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1530\/JOE-12-0178","article-title":"Biomarkers of hypothalamic-pituitary-adrenal axis activity in mice lacking 11\u03b2-HSD1 and H6PDH","volume":"214","author":"Abrahams","year":"2012","journal-title":"J Endocrinol"},{"key":"2019041121523310200_B31","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1073\/pnas.1014934108","article-title":"Cortisone-reductase deficiency associated with heterozygous mutations in 11\u03b2-hydroxysteroid dehydrogenase type 1","volume":"108","author":"Lawson","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121523310200_B32","doi-asserted-by":"crossref","first-page":"K19","DOI":"10.1530\/EJE-12-0628","article-title":"Novel H6PDH mutations in two girls with premature adrenarche: \u2018apparent\u2019 and \u2018true\u2019 CRD can be differentiated by urinary steroid profiling","volume":"168","author":"Lavery","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2019041121523310200_B33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1210\/endo.142.1.7887","article-title":"Intracellular regeneration of glucocorticoids by 11\u03b2-hydroxysteroid dehydrogenase (11\u03b2-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11\u03b2-HSD-1-deficient mice","volume":"142","author":"Harris","year":"2001","journal-title":"Endocrinology"},{"key":"2019041121523310200_B34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1210\/en.2010-0957","article-title":"Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11\u03b2-hydroxysteroid dehydrogenase type 1","volume":"152","author":"Semjonous","year":"2011","journal-title":"Endocrinology"},{"key":"2019041121523310200_B35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2826.2009.01899.x","article-title":"Hypothalamic-pituitary-adrenal axis abnormalities in response to deletion of 11\u03b2-HSD1 is strain-dependent","volume":"21","author":"Carter","year":"2009","journal-title":"J Neuroendocrinol"},{"key":"2019041121523310200_B36","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/endo-128-4-1741","article-title":"Regional distribution of 11 \u03b2-hydroxysteroid dehydrogenase in rat brain","volume":"128","author":"Lakshmi","year":"1991","journal-title":"Endocrinology"},{"key":"2019041121523310200_B37","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1210\/endo-127-3-1450","article-title":"11 \u03b2-Hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex","volume":"127","author":"Moisan","year":"1990","journal-title":"Endocrinology"},{"key":"2019041121523310200_B38","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/en.2012-1019","article-title":"Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11\u03b2-hydroxysteroid dehydrogenase type 1","volume":"153","author":"Lavery","year":"2012","journal-title":"Endocrinology"},{"key":"2019041121523310200_B39","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1073\/pnas.0305524101","article-title":"Metabolic syndrome without obesity: hepatic overexpression of 11\u03b2-hydroxysteroid dehydrogenase type 1 in transgenic mice","volume":"101","author":"Paterson","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121523310200_B40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2265.2006.02547.x","article-title":"Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome","volume":"65","author":"Draper","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121523310200_B41","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/molehr\/gas002","article-title":"Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage","volume":"18","author":"Chua","year":"2012","journal-title":"Mol Hum Reprod"},{"key":"2019041121523310200_B42","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1093\/humrep\/der222","article-title":"Genetic polymorphisms of the glucocorticoid receptor may affect the phenotype of women with anovulatory polycystic ovary syndrome","volume":"26","author":"Valkenburg","year":"2011","journal-title":"Hum Reprod"},{"key":"2019041121523310200_B43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1210\/jc.2006-1349","article-title":"Lack of association of the 11 \u03b2-hydroxysteroid dehydrogenase type 1 gene 83,557insA and hexose-6-phosphate dehydrogenase gene R453Q polymorphisms with body composition, adrenal androgen production, blood pressure, glucose metabolism, and dementia","volume":"92","author":"Smit","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B44","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1210\/jc.2005-0942","article-title":"Genotypes at 11\u03b2-hydroxysteroid dehydrogenase type 11B1 and hexose-6-phosphate dehydrogenase loci are not risk factors for apparent cortisone reductase deficiency in a large population-based sample","volume":"90","author":"White","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B45","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1210\/jc.2004-1523","article-title":"A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11 \u03b2-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome","volume":"90","author":"San Millan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B46","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1210\/jc.2005-2222","article-title":"Genetic variation in 11\u03b2-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome","volume":"91","author":"Gambineri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B47","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1530\/EJE-11-0091","article-title":"A combination of polymorphisms in HSD11B1 associates with in vivo 11\u03b2-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome","volume":"165","author":"Gambineri","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2019041121523310200_B48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/hmg\/ddg361","article-title":"Glucocorticoid-related genetic susceptibility for Alzheimer's disease","volume":"13","author":"de Quervain","year":"2004","journal-title":"Hum Mol Genet"},{"key":"2019041121523310200_B49","doi-asserted-by":"crossref","first-page":"E233","DOI":"10.1210\/jc.2011-0601","article-title":"The effect of common genetic variation in 11\u03b2-hydroxysteroid dehydrogenase type 1 on hypothalamic-pituitary-adrenal axis activity and incident depression","volume":"97","author":"Dekker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neulet.2005.09.047","article-title":"Polymorphisms in the gene encoding 11B-hydroxysteroid dehydrogenase type 1 (HSD 11B1) and lifetime cognitive change","volume":"393","author":"Deary","year":"2006","journal-title":"Neurosci Lett"},{"key":"2019041121523310200_B51","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/sj.ijo.0802327","article-title":"Associations between a polymorphism in the 11 \u03b2 hydroxysteroid dehydrogenase type I gene and body composition","volume":"27","author":"Gelernter-Yaniv","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041121523310200_B52","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/ijo.2012.4","article-title":"A gene variant of 11\u03b2-hydroxysteroid dehydrogenase type 1 is associated with obesity in children","volume":"36","author":"Olza","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"2019041121523310200_B53","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/s00125-004-1407-6","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1: genetic polymorphisms are associated with type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle","volume":"47","author":"Nair","year":"2004","journal-title":"Diabetologia"},{"key":"2019041121523310200_B54","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/01.HYP.0000144294.28985.d5","article-title":"Interaction between an 11\u03b2HSD1 gene variant and birth era modifies the risk of hypertension in Pima Indians","volume":"44","author":"Franks","year":"2004","journal-title":"Hypertension"},{"key":"2019041121523310200_B55","doi-asserted-by":"crossref","first-page":"76","DOI":"10.11613\/BM.2012.008","article-title":"Association between 11\u03b2-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in Bosnian population","volume":"22","author":"Dujic","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"key":"2019041121523310200_B56","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.bone.2009.07.080","article-title":"HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia","volume":"45","author":"Hwang","year":"2009","journal-title":"Bone"},{"key":"2019041121523310200_B57","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCGENETICS.110.958496","article-title":"Common variation at the 11-\u03b2 hydroxysteroid dehydrogenase type 1 gene is associated with left ventricular mass","volume":"4","author":"Rahman","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"2019041121523310200_B58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.steroids.2010.10.001","article-title":"Mutations of the hexose-6-phosphate dehydrogenase gene rarely cause hyperandrogenemic polycystic ovary syndrome","volume":"76","author":"Qin","year":"2011","journal-title":"Steroids"},{"key":"2019041121523310200_B59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.gene.2012.01.047","article-title":"The R453Q and D151A polymorphisms of hexose-6-phosphate dehydrogenase gene (H6PD) influence the polycystic ovary syndrome (PCOS) and obesity","volume":"497","author":"Martinez-Garcia","year":"2012","journal-title":"Gene"},{"key":"2019041121523310200_B60","doi-asserted-by":"crossref","first-page":"e23248","DOI":"10.1371\/journal.pone.0023248","article-title":"Genotype at the P554L variant of the hexose-6 phosphate dehydrogenase gene is associated with carotid intima-medial thickness","volume":"6","author":"Rahman","year":"2011","journal-title":"PLoS One"},{"key":"2019041121523310200_B61","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ng.2007.17","article-title":"Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants","volume":"39","author":"Newport","year":"2007","journal-title":"Nat Genet"},{"key":"2019041121523310200_B62","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ejhg.2009.240","article-title":"Tag-SNP analysis of the GFI1-EVI5-RPL5-FAM69 risk locus for multiple sclerosis","volume":"18","author":"Alcina","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"2019041121523310200_B63","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/j.1550-8528.1994.tb00097.x","article-title":"The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism)","volume":"2","author":"Cushing","year":"1994","journal-title":"Obes Res"},{"key":"2019041121523310200_B64","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1084\/jem.75.1.93","article-title":"Comparative diabetogenic action of the hypophysis from various animals","volume":"75","author":"Houssay","year":"1942","journal-title":"J Exp Med"},{"key":"2019041121523310200_B65","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1084\/jem.63.4.465","article-title":"The effects of adrenalectomy and hypophysectomy upon experimental diabetes in the cat","volume":"63","author":"Long","year":"1936","journal-title":"J Exp Med"},{"key":"2019041121523310200_B66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1152\/ajplegacy.1952.170.1.77","article-title":"Comparison of some metabolic and morphologic effects of cortisone and hydrocortisone given by continuous injection to rats","volume":"170","author":"Ingle","year":"1952","journal-title":"Am J Physiol"},{"key":"2019041121523310200_B67","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2337\/diab.1.5.345","article-title":"Some further studies on the relationship of adrenal cortical hormones to experimental diabetes","volume":"1","author":"Ingle","year":"1952","journal-title":"Diabetes"},{"key":"2019041121523310200_B68","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0140-6736(52)91846-1","article-title":"The endocrine control of the blood-sugar","volume":"262","author":"Long","year":"1952","journal-title":"Lancet"},{"key":"2019041121523310200_B69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jsbmb.2010.03.060","article-title":"Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes","volume":"122","author":"Gathercole","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121523310200_B70","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/01.HYP.33.6.1364","article-title":"Cortisol effects on body mass, blood pressure, and cholesterol in the general population","volume":"33","author":"Fraser","year":"1999","journal-title":"Hypertension"},{"key":"2019041121523310200_B71","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/0026-0495(92)90171-6","article-title":"Cortisol secretion in relation to body fat distribution in obese premenopausal women","volume":"41","author":"Marin","year":"1992","journal-title":"Metabolism"},{"key":"2019041121523310200_B72","first-page":"501","article-title":"Effect of fat distribution on the pharmacokinetics of cortisol in obesity","volume":"36","author":"Lottenberg","year":"1998","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2019041121523310200_B73","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2265.1998.00458.x","article-title":"Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution","volume":"48","author":"Pasquali","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121523310200_B74","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/j.1550-8528.1996.tb00546.x","article-title":"Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study","volume":"4","author":"Ljung","year":"1996","journal-title":"Obes Res"},{"key":"2019041121523310200_B75","first-page":"1022","article-title":"Cortisol metabolism in human obesity: impaired cortisone\u2192cortisol conversion in subjects with central adiposity","volume":"84","author":"Stewart","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B76","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1210\/jc.2003-032240","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus","volume":"89","author":"Valsamakis","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B77","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1464-5491.2005.01583.x","article-title":"Relationship of non-alcoholic hepatic steatosis to cortisol secretion in diet-controlled type 2 diabetic patients","volume":"22","author":"Targher","year":"2005","journal-title":"Diabet Med"},{"key":"2019041121523310200_B78","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1210\/jc.2003-030596","article-title":"Body fat distribution and cortisol metabolism in healthy men: enhanced 5\u03b2-reductase and lower cortisol\/cortisone metabolite ratios in men with fatty liver","volume":"88","author":"Westerbacka","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B79","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2265.2006.02466.x","article-title":"Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease","volume":"64","author":"Targher","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121523310200_B80","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-2265.2004.02154.x","article-title":"Relationship of nonalcoholic hepatic steatosis to overnight low-dose dexamethasone suppression test in obese individuals","volume":"61","author":"Zoppini","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121523310200_B81","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1128\/MCB.16.8.4128","article-title":"Induction of peroxisome proliferator-activated receptor \u03b3 during the conversion of 3T3 fibroblasts into adipocytes is mediated by C\/EBP\u03b2, C\/EBP\u03b4, and glucocorticoids","volume":"16","author":"Wu","year":"1996","journal-title":"Mol Cell Biol"},{"key":"2019041121523310200_B82","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1101\/gad.5.9.1538","article-title":"Regulated expression of three C\/EBP isoforms during adipose conversion of 3T3\u2013L1 cells","volume":"5","author":"Cao","year":"1991","journal-title":"Genes Dev"},{"key":"2019041121523310200_B83","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0014-4827(91)90261-R","article-title":"Glucocorticoids induce a drastic inhibition of proliferation and stimulate differentiation of adult rat fat cell precursors","volume":"196","author":"Gregoire","year":"1991","journal-title":"Exp Cell Res"},{"key":"2019041121523310200_B84","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1055\/s-2002-38255","article-title":"Human adipose tissue under in vitro inhibition of 11\u03b2-hydroxysteroid dehydrogenase type 1: differentiation and metabolism changes","volume":"34","author":"Bader","year":"2002","journal-title":"Horm Metab Res"},{"key":"2019041121523310200_B85","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0022-2275(20)41151-4","article-title":"Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes","volume":"35","author":"Slavin","year":"1994","journal-title":"J Lipid Res"},{"key":"2019041121523310200_B86","doi-asserted-by":"crossref","first-page":"47066","DOI":"10.1074\/jbc.M403855200","article-title":"Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis","volume":"279","author":"Villena","year":"2004","journal-title":"J Biol Chem"},{"key":"2019041121523310200_B87","doi-asserted-by":"crossref","first-page":"e26223","DOI":"10.1371\/journal.pone.0026223","article-title":"Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue","volume":"6","author":"Gathercole","year":"2011","journal-title":"PLoS One"},{"key":"2019041121523310200_B88","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1093\/nar\/15.16.6405","article-title":"Glucocorticoids control phosphoenolpyruvate carboxykinase gene expression in a tissue specific manner","volume":"15","author":"Nechushtan","year":"1987","journal-title":"Nucleic Acids Res"},{"key":"2019041121523310200_B89","doi-asserted-by":"crossref","first-page":"12929","DOI":"10.1074\/jbc.M300263200","article-title":"Glucocorticoids repress transcription of phosphoenolpyruvate carboxykinase (GTP) gene in adipocytes by inhibiting its C\/EBP-mediated activation","volume":"278","author":"Olswang","year":"2003","journal-title":"J Biol Chem"},{"key":"2019041121523310200_B90","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/jn\/134.5.1032","article-title":"The human fatty acid synthase gene and de novo lipogenesis are coordinately regulated in human adipose tissue","volume":"134","author":"Wang","year":"2004","journal-title":"J Nutr"},{"key":"2019041121523310200_B91","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1042\/bj1880185","article-title":"Effects of insulin, glucocorticoids and adrenaline on the activity of rat adipose-tissue lipoprotein lipids","volume":"188","author":"Ashby","year":"1980","journal-title":"Biochem J"},{"key":"2019041121523310200_B92","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1530\/eje.0.1460419","article-title":"Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes","volume":"146","author":"Buren","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"2019041121523310200_B93","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1210\/jc.2003-031157","article-title":"Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes","volume":"89","author":"Lundgren","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B94","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.2337\/diabetes.49.10.1700","article-title":"Dexamethasone-induced insulin resistance in 3T3\u2013L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction","volume":"49","author":"Sakoda","year":"2000","journal-title":"Diabetes"},{"key":"2019041121523310200_B95","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/S0021-9258(17)41975-2","article-title":"Dexamethasone down-regulation of insulin receptor substrate-1 in 3T3\u2013L1 adipocytes","volume":"269","author":"Turnbow","year":"1994","journal-title":"J Biol Chem"},{"key":"2019041121523310200_B96","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1210\/jc.2007-1399","article-title":"Glucocorticoid modulation of insulin signaling in human subcutaneous adipose tissue","volume":"92","author":"Gathercole","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B97","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1210\/me.2009-0091","article-title":"Insulin sensitization of human preadipocytes through glucocorticoid hormone induction of forkhead transcription factors","volume":"24","author":"Tomlinson","year":"2010","journal-title":"Mol Endocrinol"},{"key":"2019041121523310200_B98","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0140-6736(96)11222-8","article-title":"Does central obesity reflect \u201cCushing's disease of the omentum\u201d?","volume":"349","author":"Bujalska","year":"1997","journal-title":"Lancet"},{"key":"2019041121523310200_B99","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0960-0760(90)90397-4","article-title":"Epithelial and adipose cells isolated from mammary glands of pregnant and lactating rats differ in 11 \u03b2-hydroxysteroid dehydrogenase activity","volume":"37","author":"Quirk","year":"1990","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121523310200_B100","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1210\/endo.142.5.8168","article-title":"Regulation of expression of 11\u03b2-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines","volume":"142","author":"Tomlinson","year":"2001","journal-title":"Endocrinology"},{"key":"2019041121523310200_B101","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0960-0760(00)00029-7","article-title":"Insulin attenuates the stimulatory effects of tumor necrosis factor \u03b1 on 11\u03b2-hydroxysteroid dehydrogenase 1 in human adipose stromal cells","volume":"72","author":"Handoko","year":"2000","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121523310200_B102","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/jc.2002-020510","article-title":"Modulation of 11 \u03b2-hydroxysteroid dehydrogenase type 1 in mature human subcutaneous adipocytes by hypothalamic messengers","volume":"88","author":"Friedberg","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B103","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1210\/jc.2008-2011","article-title":"Omental adipose tissue type 1 11 \u03b2-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women","volume":"94","author":"Veilleux","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B104","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1677\/JOE-08-0050","article-title":"A novel selective 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis","volume":"197","author":"Bujalska","year":"2008","journal-title":"J Endocrinol"},{"key":"2019041121523310200_B105","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1210\/endo.140.7.6868","article-title":"Differentiation of adipose stromal cells: the roles of glucocorticoids and 11\u03b2-hydroxysteroid dehydrogenase","volume":"140","author":"Bujalska","year":"1999","journal-title":"Endocrinology"},{"key":"2019041121523310200_B106","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1677\/joe.0.1670533","article-title":"Mechanisms of dysregulation of 11 \u03b2-hydroxysteroid dehydrogenase type 1 in obese Zucker rats","volume":"167","author":"Livingstone","year":"2000","journal-title":"J Endocrinol"},{"key":"2019041121523310200_B107","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1210\/endo.141.2.7297","article-title":"Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats","volume":"141","author":"Livingstone","year":"2000","journal-title":"Endocrinology"},{"key":"2019041121523310200_B108","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1476-511X-9-132","article-title":"A novel genetically-obese rat model with elevated 11 \u03b2-hydroxysteroid dehydrogenase type 1 activity in subcutaneous adipose tissue","volume":"9","author":"Prasad","year":"2010","journal-title":"Lipids Health Dis"},{"key":"2019041121523310200_B109","doi-asserted-by":"crossref","first-page":"E1213","DOI":"10.1152\/ajpendo.00340.2006","article-title":"Bezafibrate regulates the expression and enzyme activity of 11 \u03b2-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3\u2013L1 adipocytes","volume":"292","author":"Nakano","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121523310200_B110","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1210\/en.2004-1063","article-title":"Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats","volume":"146","author":"Drake","year":"2005","journal-title":"Endocrinology"},{"key":"2019041121523310200_B111","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/oby.2004.3","article-title":"Regulation of 11\u03b2-HSD genes in human adipose tissue: influence of central obesity and weight loss","volume":"12","author":"Engeli","year":"2004","journal-title":"Obes Res"},{"key":"2019041121523310200_B112","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2265.2006.02552.x","article-title":"Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women","volume":"65","author":"Goedecke","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121523310200_B113","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1210\/jc.2004-0153","article-title":"Overexpression of 11\u03b2-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins","volume":"89","author":"Kannisto","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B114","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1210\/jc.2002-030017","article-title":"Subcutaneous adipose 11 \u03b2-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians","volume":"88","author":"Lindsay","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B115","first-page":"2701","article-title":"Expression of the mRNA coding for 11\u03b2-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study","volume":"87","author":"Paulmyer-Lacroix","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B116","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1210\/jcem.86.3.7453","article-title":"Tissue-specific dysregulation of cortisol metabolism in human obesity","volume":"86","author":"Rask","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B117","first-page":"3330","article-title":"Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11\u03b2-hydroxysteroid dehydrogenase type 1 activity","volume":"87","author":"Rask","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B118","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2337\/diabetes.54.3.872","article-title":"Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone","volume":"54","author":"Sandeep","year":"2005","journal-title":"Diabetes"},{"key":"2019041121523310200_B119","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11695-009-9937-0","article-title":"Overexpression of 11\u03b2-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients","volume":"20","author":"Baudrand","year":"2010","journal-title":"Obes Surg"},{"key":"2019041121523310200_B120","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/oby.2006.92","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients","volume":"14","author":"Desbriere","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"2019041121523310200_B121","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/oby.2007.618","article-title":"Omental 11\u03b2-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity","volume":"15","author":"Michailidou","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"2019041121523310200_B122","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/oby.2007.233","article-title":"11\u03b2-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization","volume":"15","author":"Paulsen","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"2019041121523310200_B123","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1210\/jc.2002-020687","article-title":"Expression of 11\u03b2-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity","volume":"87","author":"Tomlinson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B124","doi-asserted-by":"crossref","first-page":"14924","DOI":"10.1073\/pnas.94.26.14924","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress","volume":"94","author":"Kotelevtsev","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121523310200_B125","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/diabetes.53.4.931","article-title":"Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 \u03b2-hydroxysteroid dehydrogenase type 1-deficient mice","volume":"53","author":"Morton","year":"2004","journal-title":"Diabetes"},{"key":"2019041121523310200_B126","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11010-005-9034-1","article-title":"Translocation of long chain fatty acids across the plasma membrane\u2014lipid rafts and fatty acid transport proteins","volume":"284","author":"Ehehalt","year":"2006","journal-title":"Mol Cell Biochem"},{"key":"2019041121523310200_B127","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmet.2004.12.008","article-title":"Adipocyte\/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes","volume":"1","author":"Maeda","year":"2005","journal-title":"Cell Metab"},{"key":"2019041121523310200_B128","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1126\/science.1066285","article-title":"A transgenic model of visceral obesity and the metabolic syndrome","volume":"294","author":"Masuzaki","year":"2001","journal-title":"Science"},{"key":"2019041121523310200_B129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1172\/JCI17845","article-title":"Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice","volume":"112","author":"Masuzaki","year":"2003","journal-title":"J Clin Invest"},{"key":"2019041121523310200_B130","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2337\/diabetes.54.4.1023","article-title":"Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity","volume":"54","author":"Kershaw","year":"2005","journal-title":"Diabetes"},{"key":"2019041121523310200_B131","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"2019041121523310200_B132","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1542-3565(04)00440-9","article-title":"Nonalcoholic fatty liver disease: a review of current understanding and future impact","volume":"2","author":"Charlton","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019041121523310200_B133","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/eje.0.1490543","article-title":"Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography","volume":"149","author":"Rockall","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"2019041121523310200_B134","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1572-0241.2002.05644.x","article-title":"Acute severe steatohepatitis related to prednisolone therapy","volume":"97","author":"Dourakis","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"2019041121523310200_B135","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1111\/j.1572-0241.1999.03379.x","article-title":"Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis","volume":"94","author":"Nanki","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"2019041121523310200_B136","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/bj2120135","article-title":"The effects of glucocorticoids on insulin-stimulated lipogenesis in primary cultures of rat hepatocytes","volume":"212","author":"Amatruda","year":"1983","journal-title":"Biochem J"},{"key":"2019041121523310200_B137","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1507\/endocrj.K09E-298","article-title":"Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription","volume":"57","author":"Zhao","year":"2010","journal-title":"Endocr J"},{"key":"2019041121523310200_B138","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1042\/bj20031320","article-title":"Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone","volume":"378","author":"Dolinsky","year":"2004","journal-title":"Biochem J"},{"key":"2019041121523310200_B139","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0002-9343(72)90154-4","article-title":"Tissue effects of glucocorticoids","volume":"53","author":"Baxter","year":"1972","journal-title":"Am J Med"},{"key":"2019041121523310200_B140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ajcn\/77.1.43","article-title":"Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets","volume":"77","author":"Schwarz","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"2019041121523310200_B141","first-page":"1325","article-title":"Immunohistochemical localization of type 1 11\u03b2-hydroxysteroid dehydrogenase in human tissues","volume":"83","author":"Ricketts","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B142","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1210\/endo.136.11.7588203","article-title":"11 \u03b2-Hydroxysteroid dehydrogenase is an exclusive 11 \u03b2-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations","volume":"136","author":"Jamieson","year":"1995","journal-title":"Endocrinology"},{"key":"2019041121523310200_B143","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1677\/joe.0.1560159","article-title":"Regulation of 11 \u03b2-hydroxysteroid dehydrogenase type 1 in primary cultures of rat and human hepatocytes","volume":"156","author":"Ricketts","year":"1998","journal-title":"J Endocrinol"},{"key":"2019041121523310200_B144","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11695-011-0524-9","article-title":"Liver upregulation of genes involved in cortisol production and action is associated with metabolic syndrome in morbidly obese patients","volume":"22","author":"Torrecilla","year":"2012","journal-title":"Obes Surg"},{"key":"2019041121523310200_B145","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1365-2265.2008.03358.x","article-title":"Hepatic 11\u03b2-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis","volume":"70","author":"Konopelska","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121523310200_B146","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1478-3231.2011.02685.x","article-title":"Overexpression of 11\u03b2-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease","volume":"32","author":"Candia","year":"2012","journal-title":"Liver Int"},{"key":"2019041121523310200_B147","doi-asserted-by":"crossref","first-page":"e29531","DOI":"10.1371\/journal.pone.0029531","article-title":"A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease","volume":"7","author":"Ahmed","year":"2012","journal-title":"PLoS One"},{"key":"2019041121523310200_B148","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/diabetes.54.1.32","article-title":"Increased glucocorticoid receptor and 11\u03b2-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db\/db mice","volume":"54","author":"Liu","year":"2005","journal-title":"Diabetes"},{"key":"2019041121523310200_B149","doi-asserted-by":"crossref","first-page":"41293","DOI":"10.1074\/jbc.M103676200","article-title":"Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11\u03b2-hydroxysteroid dehydrogenase type 1 null mice","volume":"276","author":"Morton","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041121523310200_B150","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/bj3210707","article-title":"Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle","volume":"321","author":"Dimitriadis","year":"1997","journal-title":"Biochem J"},{"key":"2019041121523310200_B151","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.2337\/db09-0525","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle","volume":"58","author":"Morgan","year":"2009","journal-title":"Diabetes"},{"key":"2019041121523310200_B152","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/dmrr.944","article-title":"Glucocorticoid-mediated effects on metabolism are reversed by targeting 11 \u03b2 hydroxysteroid dehydrogenase type 1 in human skeletal muscle","volume":"25","author":"Salehzadeh","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"2019041121523310200_B153","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11010-008-9993-0","article-title":"Alteration of 11 \u03b2-hydroxysteroid dehydrogenase type 1 in skeletal muscle in a rat model of type 2 diabetes","volume":"324","author":"Zhang","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"2019041121523310200_B154","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2362.2005.01552.x","article-title":"Increased expression of 11\u03b2-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes","volume":"35","author":"Abdallah","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"2019041121523310200_B155","first-page":"2296","article-title":"Regulation of glucocorticoid receptor \u03b1 and \u03b2 isoforms and type I 11\u03b2-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance?","volume":"6","author":"Whorwood","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B156","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-0030-1269896","article-title":"Morphofunctional alterations in endocrine pancreas of short- and long-term dexamethasone-treated rats","volume":"43","author":"Rafacho","year":"2011","journal-title":"Horm Metab Res"},{"key":"2019041121523310200_B157","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.2337\/diabetes.51.2007.S117","article-title":"Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes?","volume":"51","author":"Gerich","year":"2002","journal-title":"Diabetes"},{"key":"2019041121523310200_B158","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1172\/JCI45680","article-title":"Dynamics of insulin secretion and the clinical implications for obesity and diabetes","volume":"121","author":"Seino","year":"2011","journal-title":"J Clin Invest"},{"key":"2019041121523310200_B159","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s00125-008-1137-2","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets","volume":"51","author":"Swali","year":"2008","journal-title":"Diabetologia"},{"key":"2019041121523310200_B160","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI119175","article-title":"Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets","volume":"99","author":"Lambillotte","year":"1997","journal-title":"J Clin Invest"},{"key":"2019041121523310200_B161","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/dmrr.525","article-title":"Regulation of 11 \u03b2-hydroxysteroid dehydrogenase type 1 and glucose-stimulated insulin secretion in pancreatic islets of Langerhans","volume":"21","author":"Ortsater","year":"2005","journal-title":"Diabetes Metab Res Rev"},{"key":"2019041121523310200_B162","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mce.2008.09.038","article-title":"Short-term glucocorticoid treatment increases insulin secretion in islets derived from lean mice through multiple pathways and mechanisms","volume":"301","author":"Hult","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121523310200_B163","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1172\/JCI119743","article-title":"Pancreatic \u03b2 cells are important targets for the diabetogenic effects of glucocorticoids","volume":"100","author":"Delaunay","year":"1997","journal-title":"J Clin Invest"},{"key":"2019041121523310200_B164","doi-asserted-by":"crossref","first-page":"13722","DOI":"10.1073\/pnas.1110965108","article-title":"Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11\u03b2-hydroxysteroid dehydrogenase","volume":"108","author":"Schmid","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121523310200_B165","doi-asserted-by":"crossref","first-page":"34841","DOI":"10.1074\/jbc.C000600200","article-title":"Type 1 11\u03b2-hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets","volume":"275","author":"Davani","year":"2000","journal-title":"J Biol Chem"},{"key":"2019041121523310200_B166","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbrc.2003.11.160","article-title":"Increased expression and activity of 11\u03b2-HSD-1 in diabetic islets and prevention with troglitazone","volume":"313","author":"Duplomb","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041121523310200_B167","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2337\/db11-1054","article-title":"Optimal elevation of \u03b2-cell 11\u03b2-hydroxysteroid dehydrogenase type 1 is a compensatory mechanism that prevents high fat diet-induced \u03b2-cell failure","volume":"61","author":"Turban","year":"2012","journal-title":"Diabetes"},{"key":"2019041121523310200_B168","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1073\/pnas.0812671106","article-title":"Dynamic regulation of mitochondrial function by glucocorticoids","volume":"106","author":"Du","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121523310200_B169","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ecl.2005.01.010","article-title":"The metabolic syndrome and cardiovascular risk in Cushing's syndrome","volume":"34","author":"Pivonello","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041121523310200_B170","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.20050119","article-title":"11\u03b2-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice","volume":"202","author":"Hermanowski-Vosatka","year":"2005","journal-title":"J Exp Med"},{"key":"2019041121523310200_B171","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0039-128X(01)00197-0","article-title":"Signal transduction mechanisms mediating rapid, nongenomic effects of cortisol on prolactin release","volume":"67","author":"Borski","year":"2002","journal-title":"Steroids"},{"key":"2019041121523310200_B172","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.RES.87.1.19","article-title":"Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms","volume":"87","author":"Simoncini","year":"2000","journal-title":"Circ Res"},{"key":"2019041121523310200_B173","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N Engl J Med"},{"key":"2019041121523310200_B174","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/01.HYP.31.1.459","article-title":"Localization of 2 11\u03b2-OH steroid dehydrogenase isoforms in aortic endothelial cells","volume":"31","author":"Brem","year":"1998","journal-title":"Hypertension"},{"key":"2019041121523310200_B175","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1210\/endo-129-6-3305","article-title":"11-\u03b2-Hydroxysteroid dehydrogenase in vascular smooth-muscle and heart: implications for cardiovascular responses to glucocorticoids","volume":"129","author":"Walker","year":"1991","journal-title":"Endocrinology"},{"key":"2019041121523310200_B176","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/cs0830171","article-title":"Glucocorticoids and blood pressure: a role for the cortisol\/cortisone shuttle in the control of vascular tone in man","volume":"83","author":"Walker","year":"1992","journal-title":"Clin Sci (Lond)"},{"key":"2019041121523310200_B177","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0039-128X(94)00074-M","article-title":"Bidirectional activity of 11 \u03b2-hydroxysteroid dehydrogenase in vascular smooth muscle cells","volume":"60","author":"Brem","year":"1995","journal-title":"Steroids"},{"key":"2019041121523310200_B178","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.4238\/2012.August.31.10","article-title":"11 \u03b2-Hydroxysteroid dehydrogenase type 1 gene expression is increased in ascending aorta tissue of metabolic syndrome patients with coronary artery disease","volume":"11","author":"Atalar","year":"2012","journal-title":"Genet Mol Res"},{"key":"2019041121523310200_B179","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.6192498","article-title":"Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone","volume":"221","author":"Folkman","year":"1983","journal-title":"Science"},{"key":"2019041121523310200_B180","doi-asserted-by":"crossref","first-page":"e14476","DOI":"10.1371\/journal.pone.0014476","article-title":"Glucocorticoid-mediated inhibition of angiogenic changes in human endothelial cells is not caused by reductions in cell proliferation or migration","volume":"5","author":"Logie","year":"2010","journal-title":"PLoS One"},{"key":"2019041121523310200_B181","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1542\/peds.105.1.117","article-title":"Steroid therapy of a proliferating hemangioma: histochemical and molecular changes","volume":"105","author":"Hasan","year":"2000","journal-title":"Pediatrics"},{"key":"2019041121523310200_B182","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1158\/1078-0432.CCR-05-2085","article-title":"Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells","volume":"12","author":"Yano","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2019041121523310200_B183","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/sj.bjc.6605314","article-title":"Glucocorticoid therapy and risk of bladder cancer","volume":"101","author":"Dietrich","year":"2009","journal-title":"Br J Cancer"},{"key":"2019041121523310200_B184","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1074\/jbc.M111.259325","article-title":"Increased angiogenesis protects against adipose hypoxia and fibrosis in metabolic disease-resistant 11\u03b2-hydroxysteroid dehydrogenase type 1 (HSD1)-deficient mice","volume":"287","author":"Michailidou","year":"2012","journal-title":"J Biol Chem"},{"key":"2019041121523310200_B185","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1073\/pnas.0500641102","article-title":"Preventing local regeneration of glucocorticoids by 11 \u03b2-hydroxysteroid dehydrogenase type 1 enhances angiogenesis","volume":"102","author":"Small","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121523310200_B186","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"van Staa","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2019041121523310200_B187","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMcp1012926","article-title":"Clinical practice. Glucocorticoid-induced bone disease","volume":"365","author":"Weinstein","year":"2011","journal-title":"N Engl J Med"},{"key":"2019041121523310200_B188","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/CS20040070","article-title":"Sensitivity of bone to glucocorticoids","volume":"107","author":"Cooper","year":"2004","journal-title":"Clin Sci (Lond)"},{"key":"2019041121523310200_B189","first-page":"115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr Rev"},{"key":"2019041121523310200_B190","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2010.05.005","article-title":"Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor","volume":"11","author":"Rauch","year":"2010","journal-title":"Cell Metab"},{"key":"2019041121523310200_B191","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"key":"2019041121523310200_B192","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S8756-3282(98)00084-2","article-title":"Osteoprogenitor cells in cell populations derived from mouse and rat calvaria differ in their response to corticosterone, cortisol, and cortisone","volume":"23","author":"Bellows","year":"1998","journal-title":"Bone"},{"key":"2019041121523310200_B193","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1677\/joe.0.1610455","article-title":"Characterization of 11\u03b2-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines","volume":"161","author":"Bland","year":"1999","journal-title":"J Endocrinol"},{"key":"2019041121523310200_B194","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1097-4644(20010601)81:3<453::AID-JCB1059>3.0.CO;2-Z","article-title":"Expression of 11 \u03b2-hydroxysteroid dehydrogenase in rat osteoblastic cells: pre-receptor regulation of glucocorticoid responses in bone","volume":"81","author":"Eyre","year":"2001","journal-title":"J Cell Biochem"},{"key":"2019041121523310200_B195","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S8756-3282(00)00344-6","article-title":"Expression and functional consequences of 11\u03b2-hydroxysteroid dehydrogenase activity in human bone","volume":"27","author":"Cooper","year":"2000","journal-title":"Bone"},{"key":"2019041121523310200_B196","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/me.2004-0212","article-title":"11 \u03b2-Hydroxysteroid dehydrogenase expression and glucocorticoid synthesis are directed by a molecular switch during osteoblast differentiation","volume":"19","author":"Eijken","year":"2005","journal-title":"Mol Endocrinol"},{"key":"2019041121523310200_B197","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1365-2265.2005.02281.x","article-title":"Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort Study","volume":"62","author":"Cooper","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121523310200_B198","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1359\/jbmr.2001.16.6.1037","article-title":"Modulation of 11\u03b2-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation","volume":"16","author":"Cooper","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2019041121523310200_B199","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/ard.2009.107466","article-title":"Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss","volume":"69","author":"Kaur","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2019041121523310200_B200","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1210\/en.2003-1427","article-title":"Mice deficient in 11\u03b2-hydroxysteroid dehydrogenase type 1 lack bone marrow adipocytes, but maintain normal bone formation","volume":"145","author":"Justesen","year":"2004","journal-title":"Endocrinology"},{"key":"2019041121523310200_B201","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00223-005-0297-z","article-title":"Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling","volume":"79","author":"Sher","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"2019041121523310200_B202","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1210\/jc.2003-022025","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone","volume":"88","author":"Cooper","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B203","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"2019041121523310200_B204","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1359\/jbmr.2002.17.6.979","article-title":"Osteoblastic 11\u03b2-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure","volume":"17","author":"Cooper","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2019041121523310200_B205","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1210\/en.2005-1626","article-title":"Enhancement of cortisol-induced 11 \u03b2-hydroxysteroid dehydrogenase type 1 expression by interleukin 1 \u03b2 in cultured human chorionic trophoblast cells","volume":"147","author":"Li","year":"2006","journal-title":"Endocrinology"},{"key":"2019041121523310200_B206","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/art.34414","article-title":"Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells","volume":"64","author":"Ahasan","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2019041121523310200_B207","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4049\/jimmunol.167.1.30","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages","volume":"167","author":"Thieringer","year":"2001","journal-title":"J Immunol"},{"key":"2019041121523310200_B208","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1182\/blood-2005-01-0186","article-title":"Expression of 11\u03b2-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells","volume":"106","author":"Freeman","year":"2005","journal-title":"Blood"},{"key":"2019041121523310200_B209","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4049\/jimmunol.174.2.879","article-title":"The expression of 11 \u03b2-hydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities","volume":"174","author":"Zhang","year":"2005","journal-title":"J Immunol"},{"key":"2019041121523310200_B210","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.4049\/jimmunol.176.12.7605","article-title":"Local amplification of glucocorticoids by 11 \u03b2-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes","volume":"176","author":"Gilmour","year":"2006","journal-title":"J Immunol"},{"key":"2019041121523310200_B211","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.4049\/jimmunol.179.9.6325","article-title":"Macrophages from 11\u03b2-hydroxysteroid dehydrogenase type 1-deficient mice exhibit an increased sensitivity to lipopolysaccharide stimulation due to TGF-\u03b2-mediated up-regulation of SHIP1 expression","volume":"179","author":"Zhang","year":"2007","journal-title":"J Immunol"},{"key":"2019041121523310200_B212","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/en.2011-1398","article-title":"11 \u03b2-Hydroxysteroid dehydrogenase type 1, but not type 2, deficiency worsens acute inflammation and experimental arthritis in mice","volume":"153","author":"Coutinho","year":"2012","journal-title":"Endocrinology"},{"key":"2019041121523310200_B213","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/ard.2008.090662","article-title":"Local and systemic glucocorticoid metabolism in inflammatory arthritis","volume":"67","author":"Hardy","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2019041121523310200_B214","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1440-1746.2006.04529.x","article-title":"11\u03b2-Hydroxysteroid dehydrogenase 1 and 2 expression in colon from patients with ulcerative colitis","volume":"22","author":"Zbankova","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"2019041121523310200_B215","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mce.2008.10.030","article-title":"Expression profiles of human 11 \u03b2-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases","volume":"301","author":"Stegk","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121523310200_B216","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00223-011-9512-2","article-title":"Can 11\u03b2-hydroxysteroid dehydrogenase activity predict the sensitivity of bone to therapeutic glucocorticoids in inflammatory bowel disease?","volume":"89","author":"Cooper","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"2019041121523310200_B217","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/ard.25.6.516","article-title":"Corticosteroid metabolism and rheumatoid arthritis","volume":"25","author":"Bailey","year":"1966","journal-title":"Ann Rheum Dis"},{"key":"2019041121523310200_B218","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/art.21091","article-title":"Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: possible role of the sympathetic nervous system?","volume":"52","author":"Schmidt","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2019041121523310200_B219","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mce.2010.03.003","article-title":"Local metabolism of glucocorticoids and its role in rat adjuvant arthritis","volume":"323","author":"Ergang","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121523310200_B220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1749-6632.2009.04981.x","article-title":"Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy","volume":"1179","author":"Brown","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"2019041121523310200_B221","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0006-3223(92)90079-F","article-title":"Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome","volume":"32","author":"Starkman","year":"1992","journal-title":"Biol Psychiatry"},{"key":"2019041121523310200_B222","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0003-4975(01)03502-0","article-title":"Glucocorticoids and hippocampal atrophy after heart transplantation","volume":"73","author":"Wilner","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"2019041121523310200_B223","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1096\/fasebj.14.5.779","article-title":"Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate","volume":"14","author":"Almeida","year":"2000","journal-title":"FASEB J"},{"key":"2019041121523310200_B224","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1073\/pnas.95.6.3168","article-title":"Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress","volume":"95","author":"Gould","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121523310200_B225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0006-8993(90)91734-X","article-title":"Glucocorticoid endangerment of hippocampal neurons is NMDA-receptor dependent","volume":"532","author":"Armanini","year":"1990","journal-title":"Brain Res"},{"key":"2019041121523310200_B226","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jpsychires.2007.10.003","article-title":"Effects of altered corticosteroid milieu on rat hippocampal neurochemistry and structure\u2014an in vivo magnetic resonance spectroscopy and imaging study","volume":"42","author":"Schubert","year":"2008","journal-title":"J Psychiatr Res"},{"key":"2019041121523310200_B227","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1471-4159.2008.05769.x","article-title":"Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress","volume":"108","author":"Lee","year":"2009","journal-title":"J Neurochem"},{"key":"2019041121523310200_B228","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.mp.4002101","article-title":"The amyloidogenic potential and behavioral correlates of stress","volume":"14","author":"Catania","year":"2009","journal-title":"Mol Psychiatry"},{"key":"2019041121523310200_B229","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1523\/JNEUROSCI.2797-06.2006","article-title":"Glucocorticoids increase amyloid-\u03b2 and tau pathology in a mouse model of Alzheimer's disease","volume":"26","author":"Green","year":"2006","journal-title":"J Neurosci"},{"key":"2019041121523310200_B230","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.neurobiolaging.2006.11.016","article-title":"Glucocorticoid receptor variant and risk of dementia and white matter lesions","volume":"29","author":"van Rossum","year":"2008","journal-title":"Neurobiol Aging"},{"key":"2019041121523310200_B231","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1167\/iovs.02-0514","article-title":"Serum- and glucocorticoid-regulated kinase isoform-1 and epithelial sodium channel subunits in human ocular ciliary epithelium","volume":"44","author":"Rauz","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2019041121523310200_B232","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archopht.1963.00960050484010","article-title":"Effect of corticosteroids on intraocular pressure and fluid dynamics. I. Effect of dexamethasone in normal eye","volume":"70","author":"Armaly","year":"1963","journal-title":"Arch Ophthalmol"},{"key":"2019041121523310200_B233","first-page":"1274","article-title":"Intraocular pressure response to topical corticosteroids","volume":"24","author":"Armaly","year":"1965","journal-title":"Fed Proc"},{"key":"2019041121523310200_B234","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0022-4731(76)90021-2","article-title":"Steroids and intraocular pressure","volume":"7","author":"Starka","year":"1976","journal-title":"J Steroid Biochem"},{"key":"2019041121523310200_B235","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1210\/jc.2009-2449","article-title":"Pseudotumor cerebri after surgical remission of Cushing's disease","volume":"95","author":"Kiehna","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B236","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jneuroim.2008.06.029","article-title":"Exploring the pathogenesis of IIH: an inflammatory perspective","volume":"201\u2013202","author":"Sinclair","year":"2008","journal-title":"J Neuroimmunol"},{"key":"2019041121523310200_B237","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.yfrne.2010.12.001","article-title":"11\u03b2-Hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress","volume":"32","author":"Wyrwoll","year":"2011","journal-title":"Front Neuroendocrinol"},{"key":"2019041121523310200_B238","first-page":"2037","article-title":"Expression and putative role of 11 \u03b2-hydroxysteroid dehydrogenase isozymes within the human eye","volume":"42","author":"Rauz","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2019041121523310200_B239","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1523\/JNEUROSCI.16-01-00065.1996","article-title":"11 \u03b2-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity","volume":"16","author":"Rajan","year":"1996","journal-title":"J Neurosci"},{"key":"2019041121523310200_B240","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/en.2007-0328","article-title":"Hexose-6-phosphate dehydrogenase and 11\u03b2-hydroxysteroid dehydrogenase-1 tissue distribution in the rat","volume":"149","author":"Gomez-Sanchez","year":"2008","journal-title":"Endocrinology"},{"key":"2019041121523310200_B241","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000331345","article-title":"Prenatal excess glucocorticoid exposure and adult affective disorders: a role for serotonergic and catecholamine pathways","volume":"95","author":"Wyrwoll","year":"2012","journal-title":"Neuroendocrinology"},{"key":"2019041121523310200_B242","doi-asserted-by":"crossref","first-page":"13867","DOI":"10.1523\/JNEUROSCI.2783-10.2010","article-title":"Partial deficiency or short-term inhibition of 11\u03b2-hydroxysteroid dehydrogenase type 1 improves cognitive function in aging mice","volume":"30","author":"Sooy","year":"2010","journal-title":"J Neurosci"},{"key":"2019041121523310200_B243","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1073\/pnas.0306996101","article-title":"11\u03b2-Hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics","volume":"101","author":"Sandeep","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121523310200_B244","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1073\/pnas.071562698","article-title":"Lack of tissue glucocorticoid reactivation in 11\u03b2-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments","volume":"98","author":"Yau","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121523310200_B245","doi-asserted-by":"crossref","first-page":"10487","DOI":"10.1523\/JNEUROSCI.2190-07.2007","article-title":"Enhanced hippocampal long-term potentiation and spatial learning in aged 11\u03b2-hydroxysteroid dehydrogenase type 1 knock-out mice","volume":"27","author":"Yau","year":"2007","journal-title":"J Neurosci"},{"key":"2019041121523310200_B246","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/qjmed\/hcg085","article-title":"Inhibition of 11\u03b2-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension","volume":"96","author":"Rauz","year":"2003","journal-title":"QJM"},{"key":"2019041121523310200_B247","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2010-0729","article-title":"Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11\u03b2-HSD1 and intracranial pressure regulation?","volume":"95","author":"Sinclair","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B248","first-page":"2468","article-title":"Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol","volume":"81","author":"Van Cauter","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B249","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1210\/edrv-7-3-284","article-title":"The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis","volume":"7","author":"Sapolsky","year":"1986","journal-title":"Endocr Rev"},{"key":"2019041121523310200_B250","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1210\/jc.2005-0105","article-title":"Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade","volume":"90","author":"Giordano","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B251","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jcem-73-5-1081","article-title":"Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men","volume":"73","author":"Iranmanesh","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B252","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1994.tb02556.x","article-title":"Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin","volume":"41","author":"Landin-Wilhelmsen","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121523310200_B253","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1046\/j.1532-5415.2003.51407.x","article-title":"Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study","volume":"51","author":"Payette","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"2019041121523310200_B254","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/archneur.1970.00480200024002","article-title":"Atrophy of skeletal muscle in patients with Cushing's syndrome","volume":"22","author":"Pleasure","year":"1970","journal-title":"Arch Neurol"},{"key":"2019041121523310200_B255","first-page":"365","article-title":"Oxidative respiration of skeletal muscle in experimental corticosteroid myopathy","volume":"81","author":"Vignos","year":"1973","journal-title":"J Lab Clin Med"},{"key":"2019041121523310200_B256","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00000441-197705000-00004","article-title":"Ultrastructural observations in myopathy complicating Cushing's disease","volume":"273","author":"Djaldetti","year":"1977","journal-title":"Am J Med Sci"},{"key":"2019041121523310200_B257","doi-asserted-by":"crossref","first-page":"M70","DOI":"10.1093\/gerona\/54.2.M70","article-title":"Measurement of body fat in healthy elderly men: a comparison of methods","volume":"54","author":"Ravaglia","year":"1999","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2019041121523310200_B258","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0021-9150(02)00009-6","article-title":"Changes in serum lipid levels during a 10 year period in a large Japanese population. A cross-sectional and longitudinal study","volume":"163","author":"Kuzuya","year":"2002","journal-title":"Atherosclerosis"},{"key":"2019041121523310200_B259","doi-asserted-by":"crossref","first-page":"e8475","DOI":"10.1371\/journal.pone.0008475","article-title":"Tissue-specific increases in 11\u03b2-hydroxysteroid dehydrogenase type 1 in normal weight postmenopausal women","volume":"4","author":"Andersson","year":"2009","journal-title":"PLoS One"},{"key":"2019041121523310200_B260","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1474-9726.2009.00545.x","article-title":"Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice","volume":"9","author":"Weinstein","year":"2010","journal-title":"Aging Cell"},{"key":"2019041121523310200_B261","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/archderm.144.5.666","article-title":"Looking older: fibroblast collapse and therapeutic implications","volume":"144","author":"Fisher","year":"2008","journal-title":"Arch Dermatol"},{"key":"2019041121523310200_B262","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00128071-200910020-00001","article-title":"Clinical implications of aging skin: cutaneous disorders in the elderly","volume":"10","author":"Farage","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"2019041121523310200_B263","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0889-8529(18)30080-X","article-title":"Glucocorticoid action and the clinical features of Cushing's syndrome","volume":"23","author":"Yanovski","year":"1994","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041121523310200_B264","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.0906-6705.2006.00435.x","article-title":"Glucocorticoid therapy-induced skin atrophy","volume":"15","author":"Schoepe","year":"2006","journal-title":"Exp Dermatol"},{"key":"2019041121523310200_B265","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1034\/j.1600-0846.2001.70203.x","article-title":"Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin","volume":"7","author":"Kolbe","year":"2001","journal-title":"Skin Res Technol"},{"key":"2019041121523310200_B266","first-page":"S91","article-title":"11 \u03b2-Hydroxysteroid dehydrogenase type 1 increases with age and photoexposure in human skin ex vivo","volume":"131","author":"Tiganescu","year":"2011","journal-title":"J Invest Dermatol"},{"key":"2019041121523310200_B267","first-page":"725","article-title":"The prevalence of \u201ccognitive impairment no dementia\u201d in community-dwelling elderly: a pilot study","volume":"38","author":"Low","year":"2004","journal-title":"Aust N Z J Psychiatry"},{"key":"2019041121523310200_B268","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0531-5565(94)00065-B","article-title":"Individual differences in hypothalamic-pituitary-adrenal activity in later life and hippocampal aging","volume":"30","author":"Meaney","year":"1995","journal-title":"Exp Gerontol"},{"key":"2019041121523310200_B269","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.715460","article-title":"Hippocampal aging and adrenocorticoids: quantitative correlations","volume":"202","author":"Landfield","year":"1978","journal-title":"Science"},{"key":"2019041121523310200_B270","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.psyneuen.2004.12.005","article-title":"Plasma cortisol levels, brain volumes and cognition in healthy elderly men","volume":"30","author":"MacLullich","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"2019041121523310200_B271","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1523\/JNEUROSCI.10-10-03247.1990","article-title":"Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats","volume":"10","author":"Issa","year":"1990","journal-title":"J Neurosci"},{"key":"2019041121523310200_B272","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1523\/JNEUROSCI.0731-10.2010","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 expression is increased in the aged mouse hippocampus and parietal cortex and causes memory impairments","volume":"30","author":"Holmes","year":"2010","journal-title":"J Neurosci"},{"key":"2019041121523310200_B273","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mce.2003.09.027","article-title":"A rapid screening assay for inhibitors of 11\u03b2-hydroxysteroid dehydrogenases (11\u03b2-HSD): flavanone selectively inhibits 11\u03b2-HSD1 reductase activity","volume":"212","author":"Schweizer","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121523310200_B274","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1530\/eje.0.1420200","article-title":"In the search for specific inhibitors of human 11 \u03b2-hydroxysteroid-dehydrogenases (11 \u03b2-HSDs): chenodeoxycholic acid selectively inhibits 11 \u03b2-HSD-I","volume":"142","author":"Diederich","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"2019041121523310200_B275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2005.08.006","article-title":"Endogenous selective inhibitors of 11 \u03b2-hydroxysteroid dehydrogenase isoforms 1 and 2 of adrenal origin","volume":"243","author":"Latif","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121523310200_B276","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1210\/jc.2002-021194","article-title":"Effects of the 11 \u03b2-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes","volume":"88","author":"Andrews","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B277","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1210\/jc.2006-2325","article-title":"Inhibition of 11\u03b2-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis","volume":"92","author":"Tomlinson","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B278","unstructured":"Thomson Reuters. The changing role of chemistry in drug discovery. International Year of Chemistry (IYC 2011) report. http:thomsonreuters.com\/content\/science\/pdf\/ls\/iyc2011.pdf."},{"key":"2019041121523310200_B279","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1517\/13543770902967658","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents","volume":"19","author":"Boyle","year":"2009","journal-title":"Expert Opin Ther Pat"},{"key":"2019041121523310200_B280","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ja.2008.122","article-title":"Colletoic acid, a novel 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor from Colletotrichum gloeosporioides SANK 21404","volume":"61","author":"Aoyagi","year":"2008","journal-title":"J Antibiot (Tokyo)"},{"key":"2019041121523310200_B281","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1021\/jo900287b","article-title":"Two asymmetric syntheses of AMG 221, an inhibitor of 11\u03b2-hydroxysteroid dehydrogenase type 1","volume":"74","author":"Caille","year":"2009","journal-title":"J Org Chem"},{"key":"2019041121523310200_B282","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1016\/j.bmcl.2010.03.032","article-title":"The development and SAR of pyrrolidine carboxamide 11\u03b2-HSD1 inhibitors","volume":"20","author":"Cheng","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"2019041121523310200_B283","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1021\/jm058228q","article-title":"Perhydroquinolylbenzamides as novel inhibitors of 11\u03b2-hydroxysteroid dehydrogenase type 1","volume":"48","author":"Coppola","year":"2005","journal-title":"J Med Chem"},{"key":"2019041121523310200_B284","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.bmc.2011.02.005","article-title":"Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11\u03b2-hydroxysteroid dehydrogenase 2 inhibitors","volume":"19","author":"Gaware","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"2019041121523310200_B285","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1177\/0091270010374470","article-title":"Population pharmacokinetic\/pharmacodynamic model of subcutaneous adipose 11\u03b2-hydroxysteroid dehydrogenase type 1 (11\u03b2-HSD1) activity after oral administration of AMG 221, a selective 11\u03b2-HSD1 inhibitor","volume":"51","author":"Gibbs","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"2019041121523310200_B286","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1021\/jm701551j","article-title":"2-Amino-1,3-thiazol-4(5H)-ones as potent and selective 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl\/6 mice","volume":"51","author":"Johansson","year":"2008","journal-title":"J Med Chem"},{"key":"2019041121523310200_B287","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1248\/cpb.59.46","article-title":"Identification of cyclic sulfonamide derivatives with an acetamide group as 11\u03b2-hydroxysteroid dehydrogenase 1 inhibitors","volume":"59","author":"Kim","year":"2011","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"2019041121523310200_B288","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1016\/j.bmcl.2009.02.123","article-title":"Discovery and structure-guided drug design of inhibitors of 11\u03b2-hydroxysteroid-dehydrogenase type I based on a spiro-carboxamide scaffold","volume":"19","author":"Lepifre","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"2019041121523310200_B289","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1016\/j.bmcl.2011.01.018","article-title":"Bicyclo[2.2.2]octyltriazole inhibitors of 11\u03b2-hydroxysteroid dehydrogenase type 1. Pharmacological agents for the treatment of metabolic syndrome","volume":"21","author":"Maletic","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"2019041121523310200_B290","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1021\/jm0609364","article-title":"Discovery and metabolic stabilization of potent and selective 2-amino-N-(adamant-2-yl) acetamide 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitors","volume":"50","author":"Rohde","year":"2007","journal-title":"J Med Chem"},{"key":"2019041121523310200_B291","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1016\/j.bmc.2010.08.046","article-title":"Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11\u03b2-hydroxysteroid dehydrogenase 2 inhibitors","volume":"18","author":"Stanetty","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"2019041121523310200_B292","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2174\/156802611795860988","article-title":"Small molecule 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitors","volume":"11","author":"Sun","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"2019041121523310200_B293","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1021\/jm100242d","article-title":"Discovery of a potent, orally active 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor for clinical study: identification of (S)-2-((1S,2S,4R)-bicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5 H)-one (AMG 221)","volume":"53","author":"Veniant","year":"2010","journal-title":"J Med Chem"},{"key":"2019041121523310200_B294","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jsbmb.2007.03.023","article-title":"Novel non-steroidal inhibitors of human 11\u03b2-hydroxysteroid dehydrogenase type 1","volume":"104","author":"Vicker","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121523310200_B295","doi-asserted-by":"crossref","first-page":"7048","DOI":"10.1021\/jo200958a","article-title":"Synthesis of potent and orally efficacious 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor HSD-016","volume":"76","author":"Wan","year":"2011","journal-title":"J Org Chem"},{"key":"2019041121523310200_B296","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1016\/j.bmcl.2011.05.101","article-title":"Generation of 3,8-substituted 1,2,4-triazolopyridines as potent inhibitors of human 11\u03b2-hydroxysteroid dehydrogenase type 1 (11\u03b2-HSD-1)","volume":"21","author":"Wang","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"2019041121523310200_B297","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1016\/j.bmc.2009.05.082","article-title":"Discovery of novel dual functional agent as PPAR\u03b3 agonist and 11\u03b2-HSD1 inhibitor for the treatment of diabetes","volume":"17","author":"Ye","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"2019041121523310200_B298","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jsbmb.2010.12.017","article-title":"The inhibition of human and rat 11\u03b2-hydroxysteroid dehydrogenase 2 by perfluoroalkylated substances","volume":"125","author":"Zhao","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121523310200_B299","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1021\/jm025530f","article-title":"Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11\u03b2-hydroxysteroid dehydrogenase type 1","volume":"45","author":"Barf","year":"2002","journal-title":"J Med Chem"},{"key":"2019041121523310200_B300","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s00125-002-0959-6","article-title":"Selective inhibition of 11\u03b2-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice","volume":"45","author":"Alberts","year":"2002","journal-title":"Diabetologia"},{"key":"2019041121523310200_B301","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1210\/en.2003-0344","article-title":"Selective inhibition of 11 \u03b2-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains","volume":"144","author":"Alberts","year":"2003","journal-title":"Endocrinology"},{"key":"2019041121523310200_B302","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1476-5381.2010.00826.x","article-title":"Emodin, a natural product, selectively inhibits 11\u03b2-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice","volume":"161","author":"Feng","year":"2010","journal-title":"Br J Pharmacol"},{"key":"2019041121523310200_B303","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.bcp.2011.01.020","article-title":"Anti-diabetic and anti-adipogenic effects of a novel selective 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone (KR-66344)","volume":"81","author":"Park","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"2019041121523310200_B304","doi-asserted-by":"crossref","first-page":"E1045","DOI":"10.1152\/ajpendo.00276.2007","article-title":"11\u03b2-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues","volume":"293","author":"Berthiaume","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121523310200_B305","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1210\/en.2006-1199","article-title":"Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11\u03b2-hydroxysteroid dehydrogenase type 1","volume":"148","author":"Berthiaume","year":"2007","journal-title":"Endocrinology"},{"key":"2019041121523310200_B306","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2210-8-3","article-title":"Inhibition of 11\u03b2HSD1 with the S-phenylethylaminothiazolone BVT116429 increases adiponectin concentrations and improves glucose homeostasis in diabetic KKAy mice","volume":"8","author":"Sundbom","year":"2008","journal-title":"BMC Pharmacol"},{"key":"2019041121523310200_B307","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/ijo.2009.33","article-title":"Additive action of 11\u03b2-HSD1 inhibition and PPAR-\u03b3 agonism on hepatic steatosis and triglyceridemia in diet-induced obese rats","volume":"33","author":"Berthiaume","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"2019041121523310200_B308","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.metabol.2009.07.015","article-title":"Preliminary report: pharmacologic 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibition increases hepatic fat oxidation in vivo and expression of related genes in rats fed an obesogenic diet","volume":"59","author":"Berthiaume","year":"2010","journal-title":"Metabolism"},{"key":"2019041121523310200_B309","doi-asserted-by":"crossref","first-page":"e40056","DOI":"10.1371\/journal.pone.0040056","article-title":"BVT.2733, a selective 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"2019041121523310200_B310","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1463-1326.2009.01034.x","article-title":"Antidiabetic effects of 11\u03b2-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis","volume":"11","author":"Lloyd","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"2019041121523310200_B311","doi-asserted-by":"crossref","first-page":"E1019","DOI":"10.1152\/ajpendo.00740.2009","article-title":"Effect of 11 \u03b2-hydroxysteroid dehydrogenase-1 inhibition on hepatic glucose metabolism in the conscious dog","volume":"298","author":"Edgerton","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121523310200_B312","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1124\/jpet.107.128280","article-title":"Demonstration of proof of mechanism and pharmacokinetics and pharmacodynamic relationship with 4\u2032-cyano-biphenyl-4-sulfonic acid (6-amino-pyridin-2-yl)-amide (PF-915275), an inhibitor of 11 -hydroxysteroid dehydrogenase type 1, in cynomolgus monkeys","volume":"324","author":"Bhat","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"2019041121523310200_B313","unstructured":"National Institutes of Health. A study of the effect of INCB013739 on cortisone reducing enzyme activity in obese people predisposed to diabetes. 2012. http:www.clinicaltrials.gov\/ct2\/show\/NCT00398619."},{"key":"2019041121523310200_B314","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2337\/dc09-2315","article-title":"The 11-\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy","volume":"33","author":"Rosenstock","year":"2010","journal-title":"Diabetes Care"},{"key":"2019041121523310200_B315","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1463-1326.2011.01375.x","article-title":"Effects of an 11 \u03b2-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome","volume":"13","author":"Feig","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"2019041121523310200_B316","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jash.2011.01.009","article-title":"Efficacy and safety of the selective 11\u03b2-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertension","volume":"5","author":"Shah","year":"2011","journal-title":"J Am Soc Hypertens"},{"key":"2019041121523310200_B317","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jc.2007-1912","article-title":"Modulation of 11 \u03b2-hydroxysteroid dehydrogenase (11 \u03b2 HSD) activity biomarkers and pharmacokinetics of PF-00915275, a selective 11 \u03b2 HSD1 inhibitor","volume":"93","author":"Courtney","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121523310200_B318","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2337\/db11-0931","article-title":"Salicylate downregulates 11\u03b2-HSD1 expression in adipose tissue in obese mice and in humans, mediating insulin sensitization","volume":"61","author":"Nixon","year":"2012","journal-title":"Diabetes"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/34\/4\/525\/10335375\/edrv0525.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T03:27:00Z","timestamp":1715830020000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/34\/4\/525\/2354661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,1]]},"references-count":318,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2012-1050","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,1]]}}}